Skip to Content

NVR J 250 (Exjade 250 mg)

Generic Name: deferasirox

Pill with imprint NVR J 250 is White, Round and has been identified as Exjade 250 mg. It is supplied by Novartis Corporation.

Exjade is used in the treatment of iron overload; thalassemia; hemosiderosis and belongs to the drug class chelating agents. Risk cannot be ruled out during pregnancy. Exjade 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for NVR J 250

Exjade 250 mg NVR J 250
Exjade 250 mg NVR J 250
Exjade 250 mg NVR J 250

Exjade

Generic Name
deferasirox
Imprint
NVR J 250
Strength
250 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
Chelating agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Novartis Corporation
National Drug Code (NDC)
00078-0469

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.